Effective desensitization to imiglucerase in a patient with type i Gaucher disease

Journal of Pediatrics

Volumn 155, Issue 6, 2009, Pages 940-941

  Peroni, Diego G ^a   Pescollderungg, Lydia ^b   Piacentini, Giorgio L ^a   Cassar, Walburga ^b   Boner, Attilio L ^a  

^a UNIVERSITY OF VERONA   (Italy)

^b Bozen Hospital   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSYLCERAMIDASE; IMIGLUCERASE;

ANAPHYLAXIS; ARTICLE; CASE REPORT; CHEMICALLY INDUCED DISORDER; CHILD; DESENSITIZATION; DRUG HYPERSENSITIVITY; GAUCHER DISEASE; HUMAN; IMMUNOLOGY; MALE;

ANAPHYLAXIS; CHILD; DESENSITIZATION, IMMUNOLOGIC; DRUG HYPERSENSITIVITY; GAUCHER DISEASE; GLUCOSYLCERAMIDASE; HUMANS; MALE;

EID: 73949156369     PISSN: 00223476     EISSN: 10976833     Source Type: Journal    
DOI: 10.1016/j.jpeds.2009.05.033     Document Type: Article

References (10)

1. Meikle PJ, Hopwood JJ, Clague AE, Carey WF. Prevalence of lysosomal storage disorders. JAMA 1999;281:249-54. (Pubitemid 29058114)
2. Beutler E, Grabowski GA. Gaucher disease. In: Scriver CR, Beaudet AL, Sly WS, editors. The Metabolic and Molecular Bases of Inherited Disease. 8th ed. New York, NY: McGraw-Hill Co; 2001: 3635-68.
3. Kaplan P, Andersson HC, Kacena KA, Yee JD. The clinical and demographic characteristics of non-neuronopathic Gaucher disease in 887 children at diagnosis. Arch Pediatr Adolesc Med 2006;160:603-8. (Pubitemid 43854401)
4. Weinreb NJ, Charrow J, Andersson HC, Kaplan P, Kolodny EH, Mistry P, et al. Effectiveness of enzyme replacement therapy in 1028 patients with type 1 Gaucher disease after 2 to 5 years of treatment: a report from the Gaucher Registry. Am J Med 2002;113:112-9. (Pubitemid 34804747)
5. Wenstrup RJ, Kacena KA, Kaplan P, Pastores GM, Prakash-Cheng A, Zimran A, et al. Effect of enzyme replacement therapy with imiglucerase on BMD in type 1 Gaucher disease. J Bone Miner Res 2007;22:119-26. (Pubitemid 46032604)
6. Starzyk K, Richards S, Yee J, Smith SE, Kingma W. The long-term international safety experience of imiglucerase therapy for Gaucher disease. Mol Genet Metab 2007;90:157-63. (Pubitemid 46108612)
7. Zhao H, Bailey LA, Grabowski GA. Enzyme therapy of Gaucher disease: clinical and biochemical changes during production of and tolerization for neutralizing antibodies. Blood Cells Mol Dis 2003;30:90-6. (Pubitemid 36378869)
8. Drelichman G, Ponce E, Basack N, Freigeiro D, Aversa L, Graciela E, et al. Clinical consequences of interrupting enzyme replacement therapy in children with type 1 Gaucher disease. J Pediatr 2007;151:197-201. (Pubitemid 47069396)
9. Akdis M, Akdis CA. Mechanisms of allergen-specific immunotherapy. J Allergy Clin Immunol 2007;119:780-9. (Pubitemid 46527830)
10. Wachholz PA, Durham SR. Induction of 0blocking0 IgG antibodies during immunotherapy. Clin Exp Allergy 2003;33:1171-4. (Pubitemid 37108518)